German science and technology group Merck KGaA (MRK: DE) has upgraded its full-year outlook after a second quarter in which its laboratory and semiconductor materials businesses more than covered a ...

UK-based clinical-stage pharma company Actimed Therapeutics today revealed that it has regained exclusive global rights to the anabolic-catabolic transforming agent (ACTA) S-oxprenolol from US biotech ...

US pharma major Eli Lilly (NYSE: LLY) reported second-quarter 2026 revenue of $23 billion, up 48% year-on-year from $15.6 billion in the second quarter of 2025 and well ahead of Wall Street forecasts ...

Adneuris Therapeutics, a wholly-owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced that it has ...

There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted ...

Cambridge, USA-based mRNA vaccines company Moderna announced that the US Food and Drug Administration (FDA) has approved ...

Sidera Bio is headquartered in Copenhagen, Denmark, with a U.S. presence in Cambridge, Massachusetts. The company operates across the European and U.S. biotech ecosystems and is focused on developing ...

BJS Biotechnologies was created to create and develop ultra-high speed thermocycling technology and apply it to Polymerase Chain Reaction (PCR) tests such as its flagship xxpress product, claimed to ...

A Cambridge, UK-based clinical-stage biotech pioneering a proprietary class of bicyclic peptide (Bicycle) medicines targeting oncology and other high-unmet-need diseases underserved by conventional ...

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the ...

A pharmaceutical company, based in USA, developing small molecule-based therapeutics for neurological and hepatological with a focus on addressing unmet medical need. CNX Therapeutics is a ...

A Shanghai-based biopharmaceutical company commercializing rare kidney and autoimmune treatments across Greater China and Asia-Pacific while exporting pipeline value globally through a landmark ...